EUVIMEDEUVIMED entdecken
Crossref

Conjugates of ibuprofen inhibit CHIKV infection and inflammation

Rudra N Dash, Mamidi Prabhudutta, Saikat De, Ranjit P Swain, Alok K Moharana, Bharat B Subudhi, Soma Chattopadhyay

Molecular Diversity · 2024

DOI: 10.1007/s11030-023-10654-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2024. Verfasst von Rudra N Dash und 6 weiteren Autor:innen. Beteiligte Einrichtung: Drug Development and Analysis Laboratory, School of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to be University, Kalinga Nagar, Bhubaneswar,…. Hauptthemen laut MEDLINE: Ibuprofen, Chikungunya virus, Antiviral Agents, Chikungunya Fever. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chikungunya virus infection has become a global health concern because of its high rates of morbidity and mortality in patients with preexisting conditions. Inflammation and arthritis are the major symptoms of CHIKV that persist even after clearance of CHIKV. To develop an antiviral that can reduce infection and manage inflammation independent of the CHIKV infection, ibuprofen (IBU) conjugates with sulfonamide and thiosemicarbazide were synthesized. The conjugates, IBU-SULFA, IBU-ISS and IBU-IBT significantly inhibited CHIKV infection in vitro with a selectivity index (CC50/IC50) of > 11.9, > 25.1 and > 21, respectively. The reduction in infection was attributed to the interference of the conjugates in the early stages of CHIKV life cycle. With no acute oral toxicity, these compounds significantly reduced inflammation and arthritis in rats. Unlike IBU, the conjugates were not ulcerogenic. In conclusion, the conjugation imparted anti-CHIKV properties while retaining the anti-inflammatory properties of IBU. These findings can encourage further validation and research to develop an antiviral for CHIKV to manage both infection and arthritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IbuprofenChikungunya virusAntiviral AgentsChikungunya FeverInflammationAnimalsRatsSemicarbazidesArthritisSulfonamidesChlorocebus aethiopsHumansVero Cells

Stichwörter der Autor:innen

AntiviralArthritisChikungunya virusIbuprofenSulfonamideThiosemicarbazide

Substanzen

IbuprofenAntiviral AgentsSemicarbazidesthiosemicarbazideSulfonamides

Autor:innen und Institutionen

  • Drug Development and Analysis Laboratory, School of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to be University, Kalinga Nagar, Bhubaneswar, 751003, Odisha, India.
  • Infectious Disease Biology Lab, Institute of Life Sciences, Bhubaneswar, 751023, Odisha, India.
  • Department of Microbiology (VRDL), AIIMS, Sijua, Patrapada, Bhubaneswar, 751019, Odisha, India.
  • Regional Centre for Biotechnology, Faridabad, India.
  • Drug Development and Analysis Laboratory, School of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to be University, Kalinga Nagar, Bhubaneswar, 751003, Odisha, India. bharatbhusans@gmail.com.
  • Infectious Disease Biology Lab, Institute of Life Sciences, Bhubaneswar, 751023, Odisha, India. sochat.ils@gmail.com.

Förderung

  • Science and Engineering Research Board

Zitieren

APA

Dash, R. N., Prabhudutta, M., De, S., Swain, R. P., Moharana, A. K., Subudhi, B. B., & Chattopadhyay, S. (2024). Conjugates of ibuprofen inhibit CHIKV infection and inflammation. Molecular Diversity. https://doi.org/10.1007/s11030-023-10654-2

Vancouver

Dash RN, Prabhudutta M, De S, Swain RP, Moharana AK, Subudhi BB, et al. Conjugates of ibuprofen inhibit CHIKV infection and inflammation. Molecular Diversity. 2024. doi:10.1007/s11030-023-10654-2

BibTeX
@article{Dash2024,
  author = {Dash, Rudra N and Prabhudutta, Mamidi and De, Saikat and Swain, Ranjit P and Moharana, Alok K and Subudhi, Bharat B and Chattopadhyay, Soma},
  title = {Conjugates of ibuprofen inhibit CHIKV infection and inflammation},
  journal = {Molecular Diversity},
  year = {2024},
  doi = {10.1007/s11030-023-10654-2}
}
Kostenlos starten →